BankPlus Trust Department Invests $28,000 in Intuitive Surgical, Inc. (NASDAQ:ISRG)

BankPlus Trust Department acquired a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 4th quarter, Holdings Channel reports. The fund acquired 53 shares of the medical equipment provider’s stock, valued at approximately $28,000.

Other hedge funds have also recently bought and sold shares of the company. Berbice Capital Management LLC purchased a new position in shares of Intuitive Surgical during the 4th quarter worth $26,000. MidAtlantic Capital Management Inc. acquired a new position in Intuitive Surgical in the third quarter valued at $33,000. Decker Retirement Planning Inc. acquired a new position in Intuitive Surgical in the fourth quarter valued at $36,000. Capital Performance Advisors LLP purchased a new position in Intuitive Surgical during the third quarter worth about $38,000. Finally, Sierra Ocean LLC acquired a new stake in Intuitive Surgical in the 4th quarter worth about $40,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Trading Down 2.9 %

Shares of ISRG stock opened at $573.74 on Wednesday. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00. The company has a market capitalization of $204.35 billion, a PE ratio of 89.51, a price-to-earnings-growth ratio of 5.85 and a beta of 1.39. The firm has a fifty day simple moving average of $567.01 and a 200-day simple moving average of $527.27.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Robert Desantis sold 376 shares of the company’s stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,967,734. This represents a 6.39 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Myriam Curet sold 408 shares of the firm’s stock in a transaction that occurred on Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total transaction of $240,618.00. Following the sale, the executive vice president now directly owns 353 shares of the company’s stock, valued at $208,181.75. The trade was a 53.61 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 6,240 shares of company stock valued at $3,529,040 in the last ninety days. Insiders own 0.80% of the company’s stock.

Analyst Ratings Changes

Several brokerages have recently weighed in on ISRG. Morgan Stanley upgraded shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and increased their price objective for the stock from $522.00 to $650.00 in a report on Monday, December 2nd. Piper Sandler reaffirmed an “overweight” rating and set a $670.00 price target (up previously from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. Raymond James increased their target price on Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. Finally, Jefferies Financial Group boosted their price target on Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.